Pfizer/BioNTech's adapted Omicron COVID vaccine begins EMA rolling review

Aug. 09, 2022 11:19 AM ETBioNTech SE (BNTX), PFENVAX, MRNABy: Jonathan Block, SA News Editor7 Comments

The omicron ba.4 and ba.5 for sci or medical concept 3d rendering

niphon/iStock via Getty Images

Recommended For You

Comments (7)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.